会社概要
- 正式社名: Corden Pharma International GmbH
- 登録国: Germany
- 住所: Otto-Hahn-Strasse, Plankstadt
- 従業員数: 1000 - 4999
説明:
CordenPharma is a CDMO partner supporting biotech and pharma innovators of complex modalities throughout the drug development lifecycle, providing bespoke outsourcing services from early clinical-phase development to commercialization. With scientific expertise and partnership at its core, the company delivers high-value, end-to-end services with strategic focus on peptides, oligonucleotides, customized lipid excipients, lipid nanoparticles, sterile injectables and small molecules (highly potent and regular potency).
事業活動
受託・アウトソーシングサービス
受託製造業者(CMO)
完成医薬品(製剤)
受託製造業者(CMO)
バイオ医薬品
受託製造業者(CMO)
受託包装サービス
受託製造業者(CMO)
販売市場
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Northern Europe: Denmark, Estonia, Finland, Ireland, Latvia, Lithuania, Sweden
- Southern Europe: Croatia, Greece, Italy, Malta, Portugal, Slovenia, Spain
- Eastern Europe: Bulgaria
主要製品/サービス
- 受託・アウトソーシングサービス: CordenPharma Highly Potent & Oncology Platform, CordenPharma Oligonucleotide Platform, CordenPharma Small Molecules Platform, CordenPharma Oral Formulation Tablets & Capsule Drug Products, CordenPharma Sterile Liquid Drug Products, CordenPharma Oligonucleotides Platform, CordenPharma Fully-Integrated Supply, CordenPharma API Support Services
- 完成医薬品(製剤): Early-Phase Oral Solid Dose Drug Product Innovation Centre of Excellence, CordenPharma's Early-Phase Peptide Centre of Excellence
- 包装資材: CordenPharma Injectables Platform, CordenPharma Pharma Packaging & Logistics
- バイオ医薬品: CordenPharma BotaniChol® Plant-Based Cholesterol
- 先発品原薬: CordenPharma Lipids & Carbohydrate Platform, CordenPharma Peptides Platform
認証
FDA
GMP
ISO
証明
CPHI Americas 2026
06/2026 – 06/2026
CPHI Americas 2026
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す